Do you have ANCA-associated vasculitis? If you have active disease requiring either rituzimab or cyclophosphamide treatment…you may be eligible…to participate in a clinical trial to determine whether an investigational non-steroidal treatment, when added to standard of care treatment, can improve the remission rate, kidney function, and/or improve vasculitis symptoms.
For more information, please refer to the Studies Enrolling Patients section of the Vasculitis Foundation website:
You are also encouraged to discuss this study with your doctor.
If you believe you are eligible for this study and wish to participate, please contact us @ 480-626-6656 or by email: firstname.lastname@example.org